市場調查報告書
商品編碼
1219658
乳糖□全球市場規模、份額、行業趨勢分析報告:按應用(飲料、藥品和膳食補充劑)、區域展望和預測,2022-2028 年Global Lactase Market Size, Share & Industry Trends Analysis Report By Application (Food & Beverages and Pharmaceutical Products & Dietary Supplements), By Regional Outlook and Forecast, 2022 - 2028 |
在預測期內,全球乳糖□市場規模預計將以 6.5% 的複合年增長率增長,到 2028 年將達到 3.552 億美元。
然而,最近發現一些人類社會發展出乳糖□持久性作為嬰兒期後攝入乳製品和非人乳的適應。 據說愛爾蘭人的乳糖□持久性異常高。 另一方面,地球上的大多數人都不同程度地存在乳糖□不耐症,並且是乳糖□不耐受症。 小腸中缺乏將乳糖分解成葡萄糖和半乳糖的乳糖□,是乳糖不耐症的原因。
乳糖不耐症可大致分為原發性、繼發性、先天性和發育性。 原發性乳糖不耐症的發展是因為乳糖□的量隨著年齡的增長而減少。 小腸疾病是繼發性乳糖不耐受的主要原因。 感染、炎症性腸病、乳糜瀉或其他疾病可能會造成此類損害。
COVID-19 影響分析
隨著許多國家進入封鎖狀態,COVID-19 疫情影響了供應鏈。 由於全球經濟和金融市場的不穩定,對化學中間體的需求也在下降。 因此,COVID-19 大流行帶來的限制正在對乳糖□市場產生負面影響,尤其是隨著工業設施的關閉和關閉。 大流行後客戶偏好的變化已將業務需求轉移到庫存和清算技術上,從而停止了消費。
市場增長因素
兒童和成人乳糖不耐症增加
原發性乳糖不耐症是一種在嬰兒期小腸完全形成之前發生的暫時性疾病。 經歷繼發性不耐受的成年人通常在小腸有消化問題。 此外,克羅恩病和胃腸炎等疾病會導致繼發性乳糖不耐症。 根據美國國家生物技術信息中心 (NCBI) 的數據,世界上大多數人都容易受到乳糖□功能障礙的影響。 因此,已經開發出不含乳糖的牛奶和乳製品,以幫助乳糖不耐症患者避免胃腸道問題。
增加研究和開發以確定乳糖□提取和□利用的新鮮來源
乳糖□的來源多種多樣。 現代研究和開發正在尋找包括細菌和真菌在內的新來源來提取□。 此外,通過使用□,可以提高飼料和食品的營養價值。 □還可以限制化學廢物、水的使用和產品的生產,最大限度地減少對人類和環境的威脅。 由於食品和飲料行業需要多步製造工藝,因此真菌乳糖□在酸性 pH 值下穩定。
市場製約因素
純素飲食和無奶替代品越來越受歡迎
植物奶的脂肪和糖含量極低,是脂肪攝入量很少的人的首選替代品。 專家建議兒童和對牛奶敏感或不耐受的人使用杏仁奶作為牛奶替代品。 然而,隨著素食者人數的增加,植物性食品開始受到以前偏愛乳製品的消費者的歡迎。 此外,許多醫生建議患有心髒病的患者採用植物性飲食,包括患有糖尿病和高血壓等疾病的患者。 這一因素可能會限制預期期間的市場擴張。
來源觀點
根據來源,乳糖□市場分為酵母、真菌和細菌。 2021 年,細菌部分在乳糖□市場取得了大幅增長。 長雙歧桿菌、嗜酸乳桿菌和糞腸球菌這三種重要的細菌是乳糖□基因的來源。 它們在製造無乳糖產品的同時增加了□活性,並且是非致病性的。 因為它不致病,細菌乳糖□也用於人類營養和治療。 越來越多地使用來自細菌的乳糖□是該領域發展的一個因素。
形態觀
乳糖□市場按形式分為液態和乾態。 液體部分將在 2021 年佔據乳糖□市場最大的收入份額。 液態乳糖□可加速生物和化學過程,使其成為食品和飲料的理想選擇。 此外,由於乳糖□是液體形式,它被稀釋並且可以根據應用以較低的稀釋率使用。 這樣,可以立即食用乳製品的液滴的可用性是一個很大的優勢,也是該領域擴展的一個因素。
應用展望
乳糖□市場按應用細分為食品和飲料以及藥品和膳食補充劑。 2021 年,食品和飲料領域在乳糖□市場的收入份額最大。 有些人無法在小腸中製造乳糖□。 如果沒有乳糖□,缺乏乳糖□的人就無法消化牛奶和乳製品中的天然雙醣。 當向牛奶中添加乳糖□時,它會水解牛奶中存在的天然乳糖,使其更容易消化,同時保持溫和的甜味。 □的這些特性擴大了它們在食品和飲料領域的用途,並正在推動該領域的發展。
區域展望
按區域劃分,我們分析了四個區域的乳糖□市場:北美、歐洲、亞太地區和 LAMEA。 2021 年,北美市場在乳糖□市場的收入份額最大。 該地區有大量乳糖不耐症人口,因此呈現出北美乳糖□市場的增長潛力。 美國兒科學會 (AAP) 建議乳糖不耐症患者不要食用牛奶和其他乳製品,因為這些食物可為身體提供鈣等必需營養素。
市場進入者採取的主要策略是產品發布和收購。 根據 Cardinal Matrix 中的分析,杜邦是乳糖□市場的領導者。 Koninklijke DSM N.V.、Kerry Group PLC 和 Novozymes A/S 等公司是乳糖□市場的領先創新者。
The Global Lactase Market size is expected to reach $355.2 Million by 2028, rising at a market growth of 6.5% CAGR during the forecast period.
The milk sugar lactose, also present in other dairy products, is broken down into the simple sugars glucose and galactose by the enzyme lactase. The need for lactase is anticipated to rise globally due to factors including expanding lactose-free demand and rising product research & developments in various fields of application like pharmaceutical, nutritional supplements, and baby nutrition. As a member of the galactosidase enzyme family, lactase hydrolyzes the disaccharide lactose into its component monomers of glucose and galactose.
The brush border layer of the developed enterocytes bordering the small intestine's villi is where lactase is primarily found. On chromosome 2, the LCT gene in humans encodes lactase. The ability of the lactase enzyme to continue functioning as an adult and break down lactose in milk is known as lactase persistence. After weaning, the enzyme's activity is significantly decreased in most mammals.
However, lactase persistence has lately developed in some human societies as an adaptation to the ingestion of dairy products and nonhuman milk after infancy. Irish people, in particular, have unusually high levels of lactase persistence. On the other hand, most people on the planet have varied degrees of lactose intolerance and are lactase non-persistent. Lack of the lactase enzyme in the small intestines, which breaks down lactose into glucose and galactose, is the cause of lactose intolerance.
Primary, secondary, congenital, and developmental are the four main categories of lactose intolerance. Primary lactose intolerance develops as people age because their lactase levels decrease. For the most part, the small intestinal damage is considered the main cause of secondary lactose intolerance. An infection, inflammatory bowel disease, celiac disease, or other illnesses may be accountable for such damage.
COVID-19 Impact Analysis
The COVID-19 outbreak has affected the supply chain due to the lockdown in many nations. Additionally, the outbreak decreased demand for chemical intermediates because of the unpredictability of the world economy and financial markets. Therefore, the constraints brought on by the COVID-19 pandemic have negatively impacted the lactase market, especially by the lockdowns and the closure of industrial facilities. Due to post-pandemic client preference changes, business requirements have transitioned to stock organization and liquidation techniques, with consumption at a stop.
Market Growth Factors
Increasing lactose intolerance in children and adults
Primary lactose intolerance is a transient condition that develops in early infants before the small intestine is fully formed. Adults who experience secondary intolerance typically have gastrointestinal problems in the small intestine. In addition, conditions like Crohn's disease or gastroenteritis can cause secondary lactose intolerance. According to the National Center for Biotechnology Information (NCBI), most of the world's population is susceptible to lactase insufficiency. As a result, the development of lactose-free milk and dairy products has increased, aiding those lactose intolerant in avoiding gastrointestinal issues.
Increased investigation and development to identify fresh sources for lactase extraction and enzyme use
The lactase enzyme is obtained from a variety of sources. To extract the enzyme, novel sources, including bacteria and fungi, are sought after by contemporary research and development. Additionally, the nutritional content of feed and food items is increased by applying enzymes. Enzymes also limit chemical waste, water use, and by-product production, posing minimal threats to people and the environment. Given that the food and beverage sector must go through several production processes, lactase enzymes derived from fungal sources have an acidic pH and are stable.
Market Restraining Factors
Increasing popularity of vegan diets and dairy-free alternatives
Due to its minimal fat and sugar content, plant-based milks are also a well-liked replacement for those who consume little to no fat. Experts suggest using almond milk as a workable replacement of milk for children and anyone with milk sensitivities or intolerances. However, as more individuals adopt a vegan lifestyle, plant-based foods are becoming more popular with consumers who previously preferred dairy products. Additionally, many doctors recommend plant-based diets for patients with cardiac problems, including those who also have diabetes, high blood pressure, and other illnesses. This factor can limit market expansion during the anticipated period.
Source Outlook
Based on source, the lactase market is categorized into yeast, fungi, and bacteria. The bacteria segment procured a considerable growth rate in the lactase market in 2021. Three important bacteria, Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis, are the origins of the lactase gene. These have increased enzymatic activity while producing lactose-free products and are non-pathogenic. Since they are not pathogens, lactase enzyme derived from bacteria finds use in human nutrition and for therapeutic purposes. The growing use bacteria sourced lactase is responsible for the growth of the segment.
Form Outlook
On the basis of form, the lactase market is divided into liquid and dry. The liquid segment acquired the largest revenue share in the lactase market in 2021. Since liquid lactase quickens biological and chemical processes, it is perfect for food and beverages. In addition, the lactase enzyme is diluted because it is in a liquid form and can potentially be used at lower dilutions, depending on the application. The availability of lactase liquid drops that enable people to consume dairy rather immediately is the main benefit of this form, and as such is accountable for the segment's expansion.
Application Outlook
Based on application, the lactase market is segmented into food & beverages and pharmaceutical products & dietary supplements. The food and beverages segment witnessed the maximum revenue share in the lactase market in 2021. Some individuals are unable to manufacture the lactase enzyme in the small intestines. People with lactase deficiencies cannot digest the natural disaccharide available in milk and milk products without it. When lactase is added to milk, the naturally occurring lactose in the milk is hydrolyzed, leaving it mildly sweet yet digestible. This characteristic of the enzyme broadens its use in the food and beverage sector and thus boosts the segment's growth.
Regional Outlook
On the basis of region, the lactase market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the maximum revenue share in the lactase market in 2021. The region's large population of lactose intolerant people presents a growth potential for the North American lactase market. The American Academy of Pediatrics (AAP) advises against encouraging persons who have lactose intolerance to consume milk or any other dairy product because these foods give the body essential nutrients like calcium.
The major strategies followed by the market participants are Product Launches and Acquisitions. Based on the Analysis presented in the Cardinal matrix; DuPont de Nemours, Inc. is the forerunner in the Lactase Market. Companies such as Koninklijke DSM N.V., Kerry Group PLC, Novozymes A/S are some of the key innovators in Lactase Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kerry Group PLC, Koninklijke DSM N.V., DuPont de Nemours, Inc., Novozymes A/S (Novo Holdings A/S), Chr. Hansen Holding A/S, Advanced Enzyme Technologies Limited, Oenon Holdings, Inc., Mitushi Biopharma, Natural Factors, and Amano Enzyme, Inc.
Recent Strategies Deployed in Lactase Market
Acquisitions and Mergers:
Feb-2022: Kerry completed the acquisition of two biotechnology companies, C-LEcta, a biotechnology innovation company, and Enmex which is an enzyme manufacturer. This acquisition would enhance the company's fermentation and enzyme capabilities.
Oct-2021: Royal DSM, completed the acquisition of First Choice Ingredients, a leading supplier of dairy-based savory flavorings. With this acquisition, DSM would strengthen the growth of First Choice Ingredients by delivering their products outside the US to serve the worldwide customer base. Moreover, DSM would integrate First Choice Ingredients' solutions into DSM's offering to deal with taste, texture, and health for Food & Beverage customers.
Nov-2020: Kerry completed the acquisition of Canadian company Bio-K Plus International, a probiotic company with a range of clinically supported probiotic beverage and supplement applications. This acquisition would broaden Kerry's current suite of probiotics.
Jun-2020: Novozymes completed the acquisition of PrecisionBiotics Group Limited, a healthcare company. This acquisition would focus on human health to make growth in Novozymes' business.
Product Launches and Expansions:
Nov-2020: Royal DSM unveiled its new Maxilact® Super lactase enzyme. With this launch, Royal DSM would aim to develop DSM's offering of Maxilact lactases which would allow dairy manufacturers to build clean tasting lactose-free and sugar-reduced dairy.
Nov-2020: Chr. Hansen announced the launch of next-generation Premium cultures YoFlex® Premium and nu-trish® that would produce a healthy high-textured yogurt, reducing the requirement for added ingredients.
Oct-2020: Novozymes and Firmenich, a privately owned perfume and taste company unveiled their mutually developed natural sugar reduction solution TasteGEM SWL, a sugar reduction solution, with Saphera lactase, a lactase enzyme. Combining both TasteGEM SWL with Saphera lactase, this technology would reduce sugar by up to 50% present in yogurt and other dairy products without the usage of sweeteners.
Geographical Expansions:
May-2022: Kerry Group expanded its geographical footprint by opening an advanced taste manufacturing facility in Africa. Based in KwaZulu-Natal, South Africa, this facility would provide aid in producing sustainable nutrition solutions to meet the demands of consumers across the African continent.
Jan-2022: Kerry Group expanded its business to Jeddah, Saudi Arabia, the company's largest plant in the Middle East, North Africa, and Turkey region. This plant would be utilized in the production of sustainable food ingredients to distribute them all over the Middle East.
Partnerships, Collaborations and Agreements:
Feb-2021: Kerry and Pharma Foods International Co. Ltd. (PFI), a functional food ingredient development and sales company signed a partnership that would develop, apply and sell global joint health ingredient technology for functional foods & beverages and dietary supplements to offer it to Kerry's global customers.
Market Segments covered in the Report:
By Application
By Source
By Form
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures